alexa Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.
Infectious Diseases

Infectious Diseases

Journal of AIDS & Clinical Research

Author(s): Fischer W, Perkins S, Theiler J, Bhattacharya T, Yusim K, , Fischer W, Perkins S, Theiler J, Bhattacharya T, Yusim K,

Abstract Share this page

Abstract HIV-1/AIDS vaccines must address the extreme diversity of HIV-1. We have designed new polyvalent vaccine antigens comprised of sets of 'mosaic' proteins, assembled from fragments of natural sequences via a computational optimization method. Mosaic proteins resemble natural proteins, and a mosaic set maximizes the coverage of potential T-cell epitopes (peptides of nine amino acids) for a viral population. We found that coverage of viral diversity using mosaics was greatly increased compared to coverage by natural-sequence vaccine candidates, for both variable and conserved proteins; for conserved HIV-1 proteins, global coverage may be feasible. For example, four mosaic proteins perfectly matched 74\% of 9-amino-acid potential epitopes in global Gag sequences; 87\% of potential epitopes matched at least 8 of 9 positions. In contrast, a single natural Gag protein covered only 37\% (9 of 9) and 67\% (8 of 9). Mosaics provide diversity coverage comparable to that afforded by thousands of separate peptides, but, because the fragments of natural proteins are compressed into a small number of native-like proteins, they are tractable for vaccines. This article was published in Nat Med and referenced in Journal of AIDS & Clinical Research

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version